Современные возможности комбинированной гормональной контрацепции

1. Hooper D.J. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, self-administered, online survey. Clin. Drug Investig. 2010; 30(11): 749-63.

2. Skouby S.O. Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries. Eur. J. Contracept. Reprod. Health Care. 2010; 15(Suppl. 2): S42-53.

3. Egarter C., Frey Tirri B., Bitzer J., Kaminskyy V., Oddens B.J., Prilepskaya V. et al. Women’s perceptions and reasons for choosing the pill, patch, or ring in the CHOICE study: a cross-sectional survey of contraceptive method selection after counseling. BMC Women’s Health. 2013; 13: 9.

4. Агеева Л.И., Александрова Г.А., Зайченко Н.М., Кириллова Г.Н., Леонов С.А., Огрызко Е.В., Титова И.А., Харькова Т.Л., Чумарина В.Ж., Шубочкина Е.М. Здравоохранение в России. 2017: Стат.сб./Росстат. М.; 2017.

5. Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org1; Practice Committee of the American Society for Reproductive Medicine. Fertil. Steril. 2017;107(1): 43-51.

6. Nappi R.E., Paoletti A.M., Volpe A., Chiovato L., Howard B., Weiss H., Ricciotti N. Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women. Eur. J. Contracept. Reprod. Health Care. 2014; 19(4): 285-94.

7. Krishnan S., Kiley J. The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg. Int. J. Women’s Health. 2010; 2: 235-9.

8. Martinez F., Ramirez I., Perez-Campos E., Latorre K., Lete I. Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis. Eur. J. Contracept. Reprod. Health Care 2012; 17: 7-29.

9. Stewart M., Black K. Choosing a combined oral contraceptive pill. Aust. Prescr. 2015; 38(1): 6-11.

10. Nappi R.E., Kaunitz A.M., Bitzer J. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians. Eur. J. Contracept. Reprod. Health Care. 2016; 21(2): 106-15.

11. Roth K., Zahradnik H.P., Schäfer W.R. Effects of different progestins on prostaglandin biosynthesis in human endometrial explants. Contraception. 2018; Aug 13. pii: S0010-7824(18)30394-9.

12. Uçar T., Timur Taşhan S., Aksoy Derya Y., Nacar G. An analysis of dysmenorrhoea and depressive symptoms in university students: A case-control study. Int. J. Nurs. Pract. 2018; 24(5): e12678.

13. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry. 2010; 67(5): 446-57.

14. Fan C., Song Q., Wang P., Li Y., Yang M., Liu B., Yu S.Y. Curcumin protects against chronic stress-induced dysregulation of neuroplasticity and depression-like behaviors via suppressing IL-1β pathway in pats. Neuroscience. 2018; Sep 27. pii: S0306-4522(18)30633-X.

15. Brynhildsen J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther. Adv. Drug Saf. 2014;5(5): 201-13.

16. Cibula D., Zikan M., Dusek L., Majek O. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis. Expert Rev. Anticancer Ther. 2011; 11(8): 1197-207.

17. Аганезова Н.В., Аганезов С.С. Новые технологии в гинекологии: фиксированный пролонгированный режим гормональной контрацепции. Акушерство и гинекология. 2017; 3: 154-9.

18. Kroll R., Reape K.Z., Margolis M. The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol. Contraception. 2010; 81(1): 41-8.

19. IMS Retail Audit Data Base, 2016.

20. Benson L.S., Micks E.A. Why Stop Now? Extended and continuous regimens of combined hormonal contraceptive methods. Obstet. Gynecol. Clin. North Am. 2015; 42(4): 669-81.

21. Edelman A., Micks E., Gallo M.F., Jensen J.T., Grimes D.A. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst. Rev. 2014; (7): CD004695.

22. Nappi R.E., Lete I., Lee L.K., Flores N.M., Micheletti M.C., Tang B. Real-world experience of women using extended-cyclevs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey. BMC Womens Health. 2018;18(1): 22.

23. Kroll R., Seidman L., Ricciotti N., Howard B., Weiss H. A phase 1, multicentre, openlabel study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with lowdose ethinyl estradiol supplementation. Eur. J. Contracept. Reprod. Health Care. 2015;20(4): 249-58.

24. Mendoza N., Lobo P., Lertxundi R., Correa M., Gonzalez E., Salamanca A., Sánchez-Borrego R. Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies. Eur. J. Contracept. Reprod. Health Care. 2014; 19(5): 321-39.

25. Frederick C.E., Edelman A., Carlson N.E., Rosenberg K.D., Jensen J.T. Extended-use oral contraceptives and medically induced amenor­rhea: attitudes, knowledge and prescribing habits of physicians. Contraception. 2011; 84(4): 384-9.

26. Seval D.L., Buckley T., Kuehl T.J., Sulak P.J. Attitudes and prescribing patterns of extended-cycle oral contraceptives. Contraception. 2011; 84(1): 71-5.

Поступила 13.09.2018

Принята в печать 21.09.2018